These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 25511680

  • 1. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH, Mulkens CE, van Laar J, Derks IA, Suo G, Croon-de Boer F, van Oers MH, Eldering E, Wang JY, Kater AP.
    Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
    [Abstract] [Full Text] [Related]

  • 2. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
    Dicker F, Kater AP, Prada CE, Fukuda T, Castro JE, Sun G, Wang JY, Kipps TJ.
    Blood; 2006 Nov 15; 108(10):3450-7. PubMed ID: 16741250
    [Abstract] [Full Text] [Related]

  • 3. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.
    Alonso R, López-Guerra M, Upshaw R, Bantia S, Smal C, Bontemps F, Manz C, Mehrling T, Villamor N, Campo E, Montserrat E, Colomer D.
    Blood; 2009 Aug 20; 114(8):1563-75. PubMed ID: 19541822
    [Abstract] [Full Text] [Related]

  • 4. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
    Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett W.
    Blood; 2009 Apr 16; 113(16):3744-53. PubMed ID: 19096009
    [Abstract] [Full Text] [Related]

  • 5. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
    Zhu HJ, Liu L, Fan L, Zhang LN, Fang C, Zou ZJ, Li JY, Xu W.
    Leuk Lymphoma; 2013 Dec 16; 54(12):2712-9. PubMed ID: 23517560
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
    Million K, Horvilleur E, Goldschneider D, Agina M, Raguénez G, Tournier F, Bénard J, Douc-Rasy S.
    Int J Oncol; 2006 Jul 16; 29(1):147-54. PubMed ID: 16773194
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
    Zhou X, Hao Q, Zhang Q, Liao JM, Ke JW, Liao P, Cao B, Lu H.
    Cell Death Differ; 2015 May 16; 22(5):755-66. PubMed ID: 25301064
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
    Zhang P, Liu SS, Ngan HY.
    PLoS One; 2012 May 16; 7(8):e42985. PubMed ID: 22900074
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
    Hu ZB, Liao XH, Xu ZY, Yang X, Dong C, Jin AM, Lu H.
    Cancer Med; 2016 Jan 16; 5(1):74-87. PubMed ID: 26625870
    [Abstract] [Full Text] [Related]

  • 13. Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2.
    Taebunpakul P, Sayan BS, Flinterman M, Klanrit P, Gäken J, Odell EW, Melino G, Tavassoli M.
    Apoptosis; 2012 Aug 16; 17(8):762-76. PubMed ID: 22484480
    [Abstract] [Full Text] [Related]

  • 14. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH, Liu CC, Yen CC, Gau JP, Wang WS, Tzeng CH.
    Int J Cancer; 2009 Jul 01; 125(1):71-7. PubMed ID: 19291793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.
    Mackus WJ, Kater AP, Grummels A, Evers LM, Hooijbrink B, Kramer MH, Castro JE, Kipps TJ, van Lier RA, van Oers MH, Eldering E.
    Leukemia; 2005 Mar 01; 19(3):427-34. PubMed ID: 15674362
    [Abstract] [Full Text] [Related]

  • 17. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
    Santidrián AF, Cosialls AM, Coll-Mulet L, Iglesias-Serret D, de Frias M, González-Gironès DM, Campàs C, Domingo A, Pons G, Gil J.
    Haematologica; 2007 Dec 01; 92(12):1631-8. PubMed ID: 18055986
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
    Song H, Wei M, Liu W, Shen S, Li J, Wang L.
    Histol Histopathol; 2018 Jan 01; 33(1):73-79. PubMed ID: 28287251
    [Abstract] [Full Text] [Related]

  • 19. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
    Tiwary R, Yu W, Sanders BG, Kline K.
    Breast Cancer Res; 2011 Jan 07; 13(1):R1. PubMed ID: 21214929
    [Abstract] [Full Text] [Related]

  • 20. N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.
    Ruhul Amin AR, Thakur VS, Gupta K, Agarwal MK, Wald DN, Shin DM, Agarwal ML.
    Oncogene; 2013 Feb 14; 32(7):920-9. PubMed ID: 22430213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.